|
gptkbp:instanceOf
|
gptkb:chemical_compound
gptkb:psoralen
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
D05AD02
|
|
gptkbp:brand
|
gptkb:Oxsoralen
gptkb:Uvadex
|
|
gptkbp:CASNumber
|
298-81-7
|
|
gptkbp:category
|
gptkb:coumarin
photosensitizing agent
dermatological drug
|
|
gptkbp:chemicalFormula
|
C12H8O4
|
|
gptkbp:combines
|
gptkb:UVA_light
|
|
gptkbp:contraindication
|
gptkb:liver_disease
pregnancy
sensitivity to sunlight
|
|
gptkbp:discoveredBy
|
1940s
|
|
gptkbp:eliminationHalfLife
|
1-2 hours
|
|
gptkbp:firstSynthesized
|
1940s
|
|
gptkbp:foundIn
|
gptkb:Psoralea_corylifolia
gptkb:Ammi_majus
|
|
gptkbp:hasInChIKey
|
FZJYQGFGNHCBMC-UHFFFAOYSA-N
|
|
gptkbp:hasSMILES
|
COc1c2occc2cc2ccc(=O)oc12
|
|
gptkbp:IUPACName
|
gptkb:9-methoxy-7H-furo[3,2-g][1]benzopyran-7-one
|
|
gptkbp:KEGGID
|
D00436
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
photosensitizer
|
|
gptkbp:meltingPoint
|
148-149°C
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
216.19 g/mol
|
|
gptkbp:origin
|
plant-derived
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1200692
3973
4114
DB00553
|
|
gptkbp:riskFactor
|
carcinogenicity
|
|
gptkbp:routeOfAdministration
|
oral
topical
intravenous
|
|
gptkbp:sideEffect
|
nausea
itching
increased risk of skin cancer
skin redness
|
|
gptkbp:solubility
|
slightly soluble in water
|
|
gptkbp:UNII
|
1UVR8Q1KFC
|
|
gptkbp:used_in_therapy
|
gptkb:PUVA_therapy
|
|
gptkbp:usedFor
|
treatment of psoriasis
treatment of eczema
treatment of vitiligo
|
|
gptkbp:bfsParent
|
gptkb:CYP2A6
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
methoxsalen
|